Jhandewala Foods (540850)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 147.57% and latest quarter revenue of ₹75 crore show strong demand traction.
• ROCE of 22.36% indicates efficient use of capital.
• Piotroski F-Score of 7/9 suggests relatively sound financial fundamentals.
• P/E of 9.17 and PEG of 0.11 offer apparent cheapness if growth persists.

Concerns

• Profit growth of 25.70% lags sales growth of 147.57%, signalling possible margin compression or lower quality earnings; latest quarter net margin is just 4%.
• Insufficient data: no book value, debt/equity, ROE, or promoter holding, making balance-sheet and governance assessment impossible.
• No dividend, so returns depend entirely on future capital appreciation.
• Stock is near its 52-week high after rising from ₹26.01 to ₹116.00, leaving limited margin of safety.

AI Analysis

Looking at Jhandewala Foods, I first ask whether this is a business I can understand and judge from the numbers alone. Packaged foods in India is a crowded, competitive arena, and the figures on my desk are only a snapshot. The market cap is ₹154 crore, the price is ₹116, and the P/E is just 9.17. On the surface, that looks like value. ROCE at 22.36% is respectable, and the Piotroski F-Score of 7/9 suggests decent financial health. Sales grew 147.57%, and the latest quarter shows ₹75 crore in sales with ₹3 crore net profit. Yet I notice something troubling: profit rose only 25.70% while sales more than doubled. That could mean margins are being squeezed, or that profit growth is lower quality. At ₹3 crore profit on ₹75 crore sales, the net margin is only 4%—thin for a food company with no obvious pricing power. Graham taught me that even a cheap stock can stay cheap if the business is ordinary. I see no durable moat, no dividend, and no data on book value, debt/equity, or promoter holding. Without those, I cannot judge financial strength or insider commitment. The stock has moved from ₹26.01 to ₹116.00—a nearly 346% gain. Buying near the top of the 52-week range, even at a low P/E, requires a huge margin of safety. The PEG of 0.11 would normally excite me, but it relies on growth that may not continue. If this company can maintain high growth and convert revenue into profit, it might eventually be a fast grower. But the numbers available do not yet prove that. I would need more years of consistent earnings and a cleaner balance sheet before putting my capital to work. A prudent investor can wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer